The Zenith Aortic Stent-Graft: A 5-Year Single-Center Experience
- 1 December 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 9 (6) , 719-728
- https://doi.org/10.1177/152660280200900602
Abstract
Purpose: To evaluate the efficacy and midterm results of the Zenith stent-graft in the treatment of abdominal aortic aneurysms (AAA). Methods: Since March 1994, 364 patients have undergone endovascular repair of infrarenal AAA. Of the 94 who were treated with the Zenith stent-graft from 1996 to 2002, 88 patients (82 men; mean age 72.6 ± 6.5 years, range 47–88) with at least 6-month follow-up were analyzed. Sixty-one (69.3%) patients were considered at high risk for intervention; 7 ruptured AAAs were treated emergently. In all, 68 (77.3%) bifurcated stent-grafts (including 18 TriFab systems) and 20 aortomonoiliac configurations were used. Cumulative data on endoleak, migration, secondary procedures, and survival were evaluated with Kaplan-Meier analyses. Results: Implantation success was 97.7%; 2 (2.3%) access-related failures were converted to open repair (1 immediate, 1 at 3 months). There were 3 (3.4%) graft limb thromboses (2 immediate, 1 late), 3 (3.4%) cases of colon ischemia due to embolization in 1 and hypogastric artery occlusion in 2, and 1 (1.1%) renal infarction due to embolism. Three (3.4%) patients died within 30 days. Eleven (12.5%) endoleaks and 1 (1.1%) late endograft migration were recorded. The 5-year cumulative endoleak and migration rates were 15% and 7%, respectively. Sixty-three (71.6%) patients did not present any complication related to the repair during a mean follow-up of 20.6 ± 14.9 months (range 6–68); notably, no complications were associated with the 18 TriFab systems. Six (6.8%) secondary procedures were performed (31% 5-year cumulative secondary procedural rate). All 6 (6.8%) aneurysm-related deaths (the 3 perioperative, 2 from late AAA rupture, and 1 during a secondary procedure) and 14 of 18 (20.4%) non-aneurysm—related deaths occurred in high-risk patients; the 5-year cumulative survival rates were 57% for any death and 92% for aneurysm-related deaths. Conclusions: The Zenith stent-graft appears both safe and effective in terms of midterm outcome of endovascular aortic aneurysm repair.Keywords
This publication has 42 references indexed in Scilit:
- Rupture of an Abdominal Aortic Aneurysm Secondary to Type II EndoleakEuropean Journal of Vascular and Endovascular Surgery, 2001
- Intraoperative, Perioperative and Late Complications with Endovascular Therapy of Aortic AneurysmEuropean Journal of Vascular and Endovascular Surgery, 2001
- The Impact of Stent-graft Development on Outcomeof AAA Repair – a 7-Year ExperienceEuropean Journal of Vascular and Endovascular Surgery, 2001
- An update of the Zenith endovascular graft for abdominal aortic aneurysms: Initial implantation and mid-term follow-up dataJournal of Vascular Surgery, 2001
- Need for secondary interventions after endovascular repair of abdominal aortic aneurysms. Intermediate-term follow-up results of a European collaborative registry (EUROSTAR)British Journal of Surgery, 2000
- The Impact of Stent Design on Proximal Stent-graft Fixation in the Abdominal Aorta: an Experimental StudyEuropean Journal of Vascular and Endovascular Surgery, 2000
- Changes of the Infrarenal Aortic Segment After Conventional Abdominal Aortic Aneurysm RepairEuropean Journal of Vascular and Endovascular Surgery, 2000
- Outcome in patients with a large abdominal aortic aneurysm considered unfit for surgeryBritish Journal of Surgery, 1998
- Impact of transrenal aortic endograft placement on endovascular graft repair of abdominal aortic aneurysmsJournal of Vascular Surgery, 1998
- Clinical experience with a bifurcated endovascular graft for abdominal aortic aneurysm repairJournal of Vascular Surgery, 1996